Transcribed
Reclaiming Medicine And Biotech From China
Jul 10, 2026 ·
41m 12s
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Reclaiming Medicine And Biotech From China
This automatic transcript is brought to you by
Sounder.AI
This is an automatically generated transcript. Please note that complete accuracy is not guaranteed.
Description
On this edition of The Federalist Radio Hour, Executive Chairman of Ovid Therapeutics Dr. Jeremy Levin joins Federalist Senior Elections Correspondent Matt Kittle to discuss how the biotech industry is...
show more
On this edition of The Federalist Radio Hour, Executive Chairman of Ovid Therapeutics Dr. Jeremy Levin joins Federalist Senior Elections Correspondent Matt Kittle to discuss how the biotech industry is essential for American healthcare and security, and how China has strategically advanced its biotech industry to overtake the United States'. They also discuss the distrust Americans have in health institutions and how Covid politics invaded scientific institutions to enforce an agenda.
You can find Dr. Levin's new book, Biotech in the Balance: Saving a Strategic Industry in an Age of Distrust, here.
The Federalist Foundation is a nonprofit, and we depend entirely on our listeners and readers — not corporations. If you value fearless, independent journalism, please consider a tax-deductible gift today at TheFederalist.com/donate. Your support keeps us going.
show less
You can find Dr. Levin's new book, Biotech in the Balance: Saving a Strategic Industry in an Age of Distrust, here.
The Federalist Foundation is a nonprofit, and we depend entirely on our listeners and readers — not corporations. If you value fearless, independent journalism, please consider a tax-deductible gift today at TheFederalist.com/donate. Your support keeps us going.
Information
| Author | Ricochet |
| Organization | Rich McFadden |
| Website | - |
| Tags |
Copyright 2026 - Spreaker Inc. an iHeartMedia Company
Comments